目的探讨血清高迁移率族蛋白B1(high mobility group protein B1,HMGB1)、Toll样受体-2(Toll like receptor-2,TLR-2)水平变化在胫腓骨骨折术后感染中的临床价值。方法回顾性选取2022年1月—2024年1月期间本院手术的339例胫腓骨骨折患...
supported by the National Natural Science Foundation of China(No.82172767);the External Cooperation Research Programs of Science and Technology Department Foundation of Fujian Province,China(No.2023I0038).
Combination immunotherapy has shown promising potential for enhancing the objective response rate compared to immune checkpoint blockade(ICB)monotherapy.However,combination therapy with multi-drugs is limited by the d...